Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A nitrogen-oxygen mixture is a medical gas composed primarily of nitrogen and oxygen in varying proportions. It is commonly referred to as "medical air" when the composition approximates atmospheric air (about 78% nitrogen and 21% oxygen), but therapeutic mixtures can be adjusted to meet specific clinical needs. The primary mechanism of action involves providing a controlled source of breathable gas for respiratory support, ensuring adequate oxygenation while avoiding hyperoxia or hypoxia. Oxygen from the mixture enters the lungs, diffuses across alveolar membranes into systemic circulation, binds hemoglobin, and supports cellular respiration by acting as the terminal electron acceptor in oxidative phosphorylation within mitochondria[1][4][5]. Nitrogen acts as an inert carrier gas that helps maintain appropriate partial pressures and prevents absorption atelectasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nitrogen-oxygen mixture.